dặn dò học bài xem trước bài 3 trả lời câu hỏi sự kiện nào chứng tỏ đến giữa thế kỉ xix chủ nhĩa tư bản đã thắng lợi trên phạm vi toàn thế giới

The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years pptx

The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years pptx

Ngày tải lên : 22/03/2014, 10:20
... hyaline Number (%) (17.2) 11 (37 .9) 13 (44.8) 26 1 (3. 4) (89.7) (3. 4) (3. 4) 24 (82.8) (17.2) (17.2) 20 (70) ( 13. 8) 12 (41 .3) 4 (10 .3) (3. 5) (6.9) (17.2) ( 13. 8) (6.9) ( 13. 8) Liver biopsy features ... (years) 13. 2 (4.1) 19 (65%) 30 .1 (6.5) 13 (45%) 18 (55%) 10 (34 %) 12 (41%) 12 (41%) (10%) 166.7 (125.8) 1 03. 3 (69.4) 92.9 ( 13. 0) 1 93. 6 (41.6) 149.9 (61.1) 6.2 (4.7) 14.6 (3. 7) 18 (49%) 32 .1 (8 .3) 18 ... 3. 6–5.2 8.6–12.7 112–497 11–67 55– 233 44–768 73 37 1 14 96 12 90 100 100 60.6 72.7 77 .3 53 87.9 Normal range{ 10–45 26 31 98–1276 6 31 0.1–1.0 3. 5–5.0 8.4–12.0 ,200 { , 130 { ,100 Negative Negative *Refers...
  • 7
  • 487
  • 0
Báo cáo khoa học: "Human vascular adhesion proteın-1 (VAP-1): Serum levels for hepatocellular carcinoma in non-alcoholic and alcoholic fatty liver disease" pdf

Báo cáo khoa học: "Human vascular adhesion proteın-1 (VAP-1): Serum levels for hepatocellular carcinoma in non-alcoholic and alcoholic fatty liver disease" pdf

Ngày tải lên : 09/08/2014, 03:22
... 2010, 8: 83 http://www.wjso.com/content/8/1/ 83 Page of Table Levels of VAP-1 (ng/mL) Cirrhosis Total HCC HCC-AFL HCC-NAFL (n = 46) VAP-1 (n = 55) (n = 33 ) (n = 22) 98.4 ± 12.6 105.0 ± 10.2 104 .3 ± ... plus HCC Cirrhosis Number Age (years) HCC 46 55 56.4 ± 8.6 58.9 ± 7 .3 Male:Female 27:19 39 :16 Alcoholic:non-alcoholic 30 :16 30 :25 Portal vein invasion NA 11 Single nodule Two nodules NA NA 14 ... Oncology 2010, 8: 83 http://www.wjso.com/content/8/1/ 83 11 12 13 14 15 16 17 18 19 20 21 22 Page of adhesion molecule PECAM-1 includes production of a soluble form J Biol Chem 1994, 269:171 83- 91 Dunlop...
  • 4
  • 294
  • 0
Báo cáo y học: "Elevated endotoxin levels in non-alcoholic fatty liver disease" potx

Báo cáo y học: "Elevated endotoxin levels in non-alcoholic fatty liver disease" potx

Ngày tải lên : 11/08/2014, 03:20
... 6.05 Control 3. 45 NAFLD NASH 3. 4 3. 35 3. 3 3. 25 *** 3. 6 Mean log sTNFRII levels Mean log sTNFRII levels 6.2 6.15 D) Control Vs NASH *; NAFLD Vs NASH*** 3. 5 3. 55 3. 5 3. 45 3. 4 3. 35 3. 3 3. 25 Control ... Insulin (μU/mL) # 18 .3( 8.1, 22 .3) 30 .4(14.6, 36 .3) Fibrosis score: 16.7(8.1, 21.1) 29.1(9.8, 26.2) 37 .2(8.7, 76 .3) 26.8(14.2, 33 .4) NA 27.4(16 .3, 36 .9) NA 38 .6(18.4, 67.2) NA 37 .0(17.6, 54.8) Glucose ... 1851.2( 131 9 .3, 2408 .3 1642.2( 130 2.1, 1857.5) 1747.1(1747.1, 1747.1) 1829 .3( 1558.2, 22 53. 3) NA 1870.0(1680.2, 2080.5) NA 2000 .3( 136 1.0, 2460.1) sTNFRII (pg/mL) # 2097 .3( 1642.424 53. 7) 2676.9(2075.6, 30 34.2)...
  • 10
  • 364
  • 0
Báo cáo y học: " Elevated endotoxin levels in non-alcoholic fatty liver disease" pdf

Báo cáo y học: " Elevated endotoxin levels in non-alcoholic fatty liver disease" pdf

Ngày tải lên : 11/08/2014, 06:22
... 6.05 Control 3. 45 NAFLD NASH 3. 4 3. 35 3. 3 3. 25 *** 3. 6 Mean log sTNFRII levels Mean log sTNFRII levels 6.2 6.15 D) Control Vs NASH *; NAFLD Vs NASH*** 3. 5 3. 55 3. 5 3. 45 3. 4 3. 35 3. 3 3. 25 Control ... Insulin (μU/mL) # 18 .3( 8.1, 22 .3) 30 .4(14.6, 36 .3) Fibrosis score: 16.7(8.1, 21.1) 29.1(9.8, 26.2) 37 .2(8.7, 76 .3) 26.8(14.2, 33 .4) NA 27.4(16 .3, 36 .9) NA 38 .6(18.4, 67.2) NA 37 .0(17.6, 54.8) Glucose ... 1851.2( 131 9 .3, 2408 .3 1642.2( 130 2.1, 1857.5) 1747.1(1747.1, 1747.1) 1829 .3( 1558.2, 22 53. 3) NA 1870.0(1680.2, 2080.5) NA 2000 .3( 136 1.0, 2460.1) sTNFRII (pg/mL) # 2097 .3( 1642.424 53. 7) 2676.9(2075.6, 30 34.2)...
  • 10
  • 416
  • 0
Báo cáo y học: " Hepatoprotective effects of Spirulina maxima in patients with non-alcoholic fatty liver disease: a case series" ppsx

Báo cáo y học: " Hepatoprotective effects of Spirulina maxima in patients with non-alcoholic fatty liver disease: a case series" ppsx

Ngày tải lên : 11/08/2014, 12:20
... 46 .3 21.5 -54 35 .6 22.6 -37 133 .3 88.0 -34 TAG (mg/dL) 76.9 52.9 -32 171.0 146.4 -15 129.8 114 .3 -12 TC (mg/dL) 216 .3 209.0 -4 275.6 205.6 -26 250.6 200.9 -20 HDL-C (mg/dL) 48.1 55.6 +15 38 .6 36 .3 ... HDL-C (mg/dL) 48.1 55.6 +15 38 .6 36 .3 -6 49.1 47.6 -3 TC/HDL-C 4.5 3. 8 -16.5 7.1 5.7 -20.7 5.1 4.2 -17 .3 LDL-C (mg/dL) 152.8 142.8 -7 2 03. 0 136 .3 -33 174.9 130 .1 -26 ALT: alanine aminotransferase, ... Gastroenterol 2007, 13( 34):4 539 -4550 Wei Y, Rector RS, Thyfault JP, Ibdah JA: Non-alcoholic fatty liver disease and mitochondrial dysfunction World J Gastroenterol 2008, 14(2):1 93- 199 Begriche K,...
  • 5
  • 404
  • 0
Báo cáo khoa học: Deficiency in apolipoprotein E has a protective effect on diet-induced nonalcoholic fatty liver disease in mice pot

Báo cáo khoa học: Deficiency in apolipoprotein E has a protective effect on diet-induced nonalcoholic fatty liver disease in mice pot

Ngày tải lên : 05/03/2014, 23:20
... (2011) 31 19 31 29 ª 2011 The Authors Journal compilation ª 2011 FEBS E A Karavia et al 24 25 26 27 28 29 30 31 32 lipoprotein-triglyceride secretion by the liver J Biol Chem 274, 35 711 35 718 Ferre ... triglyceride-rich lipoproteins [39 ]), as described previously [26 ,36 ,37 ,40] Serum samples were isolated at 30 , 60, 90, 120, 150 and 180 after injection with Triton-WR 133 9 As a control, serum samples were isolated ... FEBS Journal 278 (2011) 31 19 31 29 ª 2011 The Authors Journal compilation ª 2011 FEBS 31 23 Apolipoprotein E and diet-induced NAFLD E A Karavia et al In agreement with our previous studies, LDLr)...
  • 11
  • 544
  • 0
Trends in Nonalcoholic Fatty Liver Disease–related Hospitalizations in US Children, Adolescents, and Young Adults pot

Trends in Nonalcoholic Fatty Liver Disease–related Hospitalizations in US Children, Adolescents, and Young Adults pot

Ngày tải lên : 14/03/2014, 11:20
... than in girls in many (9,11,22 36 ) but not all screening studies (10, 13, 37 39 ) Some studies used ALT as a surrogate marker for NAFLD (9,11, 23, 25,27,29 ,31 ,34 ,36 ,37 ,39 ) and therefore may be subject ... which based the diagnosis of NAFLD on ultrasound (24,27–29 ,33 ,35 ), liver biopsy (22,26 ,30 ,32 ,39 ), and magnetic resonance imaging ( 23) The higher prevalence among boys is fairly consistent across ... 1922 to 1 935 N Engl J Med 1992 ;32 7: 135 0–5 48 Baker JL, Olsen LW, Sorensen TI Childhood body-mass index and the risk of coronary heart disease in adulthood N Engl J Med 2007 ;35 7: 232 9 37 6 03 49 Bibbins-Domingo...
  • 7
  • 421
  • 0
Nonalcoholic fatty liver disease in children living in the obeseogenic society doc

Nonalcoholic fatty liver disease in children living in the obeseogenic society doc

Ngày tải lên : 22/03/2014, 10:20
... nonalcoholic fatty liver disease J Hepatol 20 03; 38 :32 -38 39 Diehl AM, Li ZP, Lin HZ, Yang SQ Cytokines and 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 World J Pediatr, Vol No November 15, ... 2004;8:521- 533 , viii 81 Vajro P, Fontanella A, Perna C, Orso G, Tedesco M, De Vincenzo A Persistent hyperaminotransferasemia resolving after weight reduction in obese children J Pediatr 1994;125: 239 -241 ... Med Biol Res 2005 ;38 :747-7 53 37 Shimada M, Hashimoto E, Kaneda H, Noguchi S, Hayashi N Nonalcoholic steatohepatitis: risk factors for liver fibrosis Hepatol Res 2002;24:429- 438 38 Sumida Y, Nakashima...
  • 10
  • 316
  • 0
Fatty Liver Disease: NASH and Related Disorders ppt

Fatty Liver Disease: NASH and Related Disorders ppt

Ngày tải lên : 22/03/2014, 16:20
... obesity [ 23, 43, 83] , diabetes [22, 23, 43] , age [ 43, 83, 148], arterial hypertension [48,105], AST : ALT ratio [ 43, 149,150], triglycerides [ 83] , elevated ALT [48, 83] , iron [44], extent of steatosis [ 83, ... insulin secretion and specific asso- 32 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ciation with the insulin resistance syndrome Hepatology 2002; 35 : 37 3–8 Amarapurkar DN, Amarapurkar AD Non-alcoholic ... 43: 26 31 63 Graif M, Yanuka M, Baraz M Quantitative estimation of attenuation in ultrasound video images: correlation with histology in diffuse liver disease Invest Radiol 2000; 35 : 31 9–24 33 ...
  • 334
  • 451
  • 0
Obesity and Air Pollution: Global Risk Factors for Pediatric Non-alco- holic Fatty Liver Disease potx

Obesity and Air Pollution: Global Risk Factors for Pediatric Non-alco- holic Fatty Liver Disease potx

Ngày tải lên : 29/03/2014, 18:20
... 2002;21(9):10 23- 32; quiz 33 -4 39 Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C Prevalence of fatty liver in children and adolescents Pediatrics 2006;118(4): 138 8- 93 40 Fraser ... Vrhovski-Hebrang D, Preden-Kerekovic V Pediatric reference intervals for 34 biochemical analytes in urban school children and adolescents Clin Chem Lab Med 1998 ;36 (5) :32 7 -37 32 Burritt MF, Slockbower ... Intern Med 2002; 137 (1):1-10 35 Hamer OW, Aguirre DA, Casola G, Lavine JE, Woenckhaus M, Sirlin CB Fatty liver: imaging patterns and pitfalls Radiographics 2006;26(6):1 637 - 53 36 Shin DS, Jeffrey...
  • 9
  • 552
  • 0
Báo cáo hóa học: " Exploring the molecular mechanisms underlying the potentiation of exogenous growth hormone on alcohol-induced fatty liver diseases in mice" ppt

Báo cáo hóa học: " Exploring the molecular mechanisms underlying the potentiation of exogenous growth hormone on alcohol-induced fatty liver diseases in mice" ppt

Ngày tải lên : 18/06/2014, 16:20
... 1.17 ± 0 .32 TC (mmol/l) 4.04 ± 0.48 3. 95 ± 0 .36 3. 91 ± 0.47 3. 99 ± 0.60 4.10 ± 0 .35 4.08 ± 0.28 IGF-1 (ng/ml) 39 3.95 ± 46.65 415 .32 ± 39 .97 38 4. 53 ± 38 .75 400.55 ± 50.78 39 9.05 ± 34 .67 38 7 .37 ± 21.68 ... prevents alcohol-induced 21 24 25 26 27 28 29 30 31 32 33 34 35 36 37 fatty liver in rats through up-regulation of c-Met Gastroenterology 2004, 126:8 73- 885 Ji C, Kaplowitz N: Betaine decreases hyperhomocysteinemia, ... 6.78 ± 0.62 10. 83 ± 2.07* 7.71 ± 0 .38 * # 8.77 ± 94# 6.92 ± 0.92 8.20 ± 1.77# 6.88 ± 0.47 8.80 ± 1. 93# Hepatic MDA (μM) 3. 39 ± 1.09 2.27 ± 0.67* 3. 77 ± 1. 03 2.87 ± 0.81 3. 17 ± 0.92 3. 05 ± 0.59 ##...
  • 15
  • 392
  • 0
Báo cáo y học: " Discovery of serum biomarkers of alcoholic fatty liver in a rodent model: C-reactive protein" doc

Báo cáo y học: " Discovery of serum biomarkers of alcoholic fatty liver in a rodent model: C-reactive protein" doc

Ngày tải lên : 10/08/2014, 10:20
... 1. 13 ± 0. 63 NASH (19) F1~F2 (19, 100%) Stage 0~1 (7, 37 %) Stage 0~4 (18, 95%) ND 0.74 ± 0 .39 * Stage 2 ~3 (12, 63% ) Stage 5~ 13 (1, 5%) F1~F2 (7, 41%) Stage 0~1 (15, 88%) Stage 0~4 (2, 12%) 1 .31 ... Mediterranean women Eur J Clin Nutr 2010, 64:8 73- 878 18 Oda E: CRP may be superior to anthropometric markers of obesity Circ J 2007, 71: 133 2, author reply 133 2- 133 3 19 Martinez VB, Gonzalez-Juanatey JR: ... 7% +4.71 Afm Afamin 4 931 1/6.14 59% +1.64 0.04 Afp Alpha-fetoprotein 47195/5.47 3% § +1.46 0. 03 Hp Haptoglobin 39 052/6.10 48% -11.54 0.04 Gc Vitamin D-binding protein 534 93/ 5.65 4%§ -1.74 0.04...
  • 10
  • 486
  • 0
Fatty Liver Disease : Nash and Related Disorders - part 1 ppt

Fatty Liver Disease : Nash and Related Disorders - part 1 ppt

Ngày tải lên : 10/08/2014, 15:20
... 921 03- 8450, USA Associate Professor of Internal Medicine, Saint Louis University School of Medicine, Division of Gastroenterology and Hepatology, 36 35 Vista Avenue, PO Box 15250, St Louis, MO 631 10-0250, ... mellitus, and alcohol Hepatology 2002; 36 : 729 36 30 Negro F Hepatitis C and liver steatosis: is it the virus? Yes it is, but not always Hepatology 2002; 36 : 1050–2 31 Adinolfi LE, Gambardella M, Andreana ... C Farrell Index, 30 3 Colour plate section appears after page 22 vi CONTRIBUTORS Geraldine M Grant Center for Liver Diseases, Inova Fairfax Hospital, Department of Medicine, 33 00 Gallows Road,...
  • 32
  • 213
  • 0
Fatty Liver Disease : Nash and Related Disorders - part 3 potx

Fatty Liver Disease : Nash and Related Disorders - part 3 potx

Ngày tải lên : 10/08/2014, 15:20
... provisional report from the WHO consultation Diabetes Med 1999; 16: 442 3 13 Comert B, Mas MR, Erdem H et al Insulin resistance in non-alcoholic steatohepatitis Dig Liver Dis 2001; 33 : 35 3–8 ... 1999; 116: 14 13 32 Bucala R, Makita Z, Koschinsky T, Cerami A, Vlassara H Lipid advanced glycosylation: pathway for lipid oxidation in vivo Proc Natl Acad Sci USA 19 93; 90: 6 434 –8 33 Quinones-Galvan ... diabetes Diabetologia 2000; 43: 995–9 38 Day CP, Saksena S, Leathart JB et al Genetic evidence supporting the two-hit model of NASH pathogenesis Hepatology 2002; 36 : 38 3A 39 Fan C-Y, Usuda N, Yeldandi...
  • 34
  • 342
  • 0
Fatty Liver Disease : Nash and Related Disorders - part 4 pot

Fatty Liver Disease : Nash and Related Disorders - part 4 pot

Ngày tải lên : 10/08/2014, 15:20
... oxidation [32 34 ] Recent evidence supports an important role for fatty acids in apoptosis, cellular insulin resistance and pancreatic β-cell failure in diabetes mellitus [1 ,3, 12, 23, 35 ,36 ] The mechanisms ... phenotypes J Clin Invest 20 03; 111: 737 –47 32 Lin HZ, Yang SQ, Kujhada F et al Metformin reverses fatty liver disease in obese, leptin-deficient mice Nat Med 2000; 6: 998–10 03 33 Li Z, Yang S, Lin H ... Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease Hepatology 20 03; 37 : 34 3–50 34 Baffy G, Zhang C-Y, Glickman JN, Lowell BB Obesityrelated...
  • 34
  • 264
  • 0
Fatty Liver Disease : Nash and Related Disorders - part 5 pdf

Fatty Liver Disease : Nash and Related Disorders - part 5 pdf

Ngày tải lên : 10/08/2014, 15:20
... mice J Hepatol 20 03; 38 : A 83 Svegliati-Baroni G, Ridolfi F, Di Sario A et al Insulin and insulin-like growth factor-1 stimulate proliferation and 29 30 31 32 33 34 35 36 37 38 39 40 41 42 type ... et al [ 13] Harrison & Hayashi [6] Chitturi et al [49] 20 42 33 144 102 93 54 49 47 51 51 49 35 17 58 33 57 60 67 62 21 27 74 ND 25 36 21 28 42 29 90 95 39 60 73 57 15 ND 18 ND 58 ND 38 96 ND ... Nature 1997; 38 9: 610– 43 Li Z, Yang S, Lin H et al Probiotics and antibodies to TNF inhibit inflammatory activity and improve non-alcoholic fatty liver disease Hepatology 20 03; 37 : 34 3–50 44 Chitturi...
  • 34
  • 383
  • 0
Fatty Liver Disease : Nash and Related Disorders - part 6 docx

Fatty Liver Disease : Nash and Related Disorders - part 6 docx

Ngày tải lên : 10/08/2014, 15:20
... García-Monzón [31 ] 32 Brunt 50.5 41 65 84 16 Ratziu et al [5] 93 METAVIR 29.1 49 34 84 16 Dixon et al [19] 26 Brunt 47.2 44 58 59 41 Chitturi et al [7] 93 Brunt 32 49 40 67 33 102 Brunt 33 .9 51 .3 43 81 ... Proc 2000; 75: 733 –9 19 Dixon JB, Bhathal PS, O’Brien PE Non-alcoholic fatty liver disease: predictors of non-alcoholic steatohepatitis 166 20 21 22 23 24 25 26 27 28 29 30 31 32 33 and liver fibrosis ... diabetes N Engl J Med 20 03; 34 8: 38 3– 93 28 Sasaki A, Horiuchi N, Hasegawa K, Uehara M Mortality and causes of death in type diabetic patients Diabetes Res Clin Pract 1989; 7: 33 –40 29 Caldwell SH,...
  • 34
  • 353
  • 0
Fatty Liver Disease : Nash and Related Disorders - part 7 ppsx

Fatty Liver Disease : Nash and Related Disorders - part 7 ppsx

Ngày tải lên : 10/08/2014, 15:20
... Lanka (Kelaniya) 13 39 34 9:4 30 : 27 : 33 % NA 44% 33 % NA 35 % 15% NA 41% 55 32 38 ∗ Type diabetes Dyslipidaemia Severe liver fibrosis Reference 11 Bridging fibrosis 12% Cirrhosis 7% 12 13 14 15 NA, data ... 169– 83 Neuschwander-Tetri BA, Sponseller C, Hamptom KK et al Rosiglitazone improves insulin sensitivity, ALT and hepatic steatosis in patients with non-alcoholic steatohep- 206 33 34 35 36 37 38 39 ... hyperinsulinemia 24 25 26 27 28 29 30 31 32 33 34 35 36 among the Japanese-Americans living in Hawaii and Los Angeles Diabetes Res Clin Pract 1994; 24 (Suppl.): S37–42 Angulo P, Keach JC, Batts...
  • 34
  • 289
  • 0
Fatty Liver Disease : Nash and Related Disorders - part 8 potx

Fatty Liver Disease : Nash and Related Disorders - part 8 potx

Ngày tải lên : 10/08/2014, 15:20
... (19 83) [2] Kinugasa et al (1984) [3] Baldridge et al (1995) [4] Rashid & Roberts (2000) [6]* 100 100 100 83 30.1 kg/m2 144% IBW 159% IBW 147% IBW NS NS NS 36 13 11 33 NS 29 44 94 88 147% IBW 31 .3 ... receiving total parenteral nutrition J Formos Med Assoc 1995; 94: 5 93 9 29 Sokol RJ, Taylor SF, Devereaux MW et al Hepatic oxidant injury and glutathione depletion during total 30 31 32 33 34 35 36 ... of JIB* 132 1 03 88 27 180 4 53 EE 43 23 ES ES EE ES ES ES Cirrhosis Portal (P) Central (C) 4.5 6.5 3. 4 4%b → 26%a 3. 2% 6.1% 8.1% 7% ND** ND ND ND 9.8%b → 32 %a 8.6%b → 48%a b a 80% → 93% 26%b →...
  • 34
  • 454
  • 0
Fatty Liver Disease : Nash and Related Disorders - part 10 pdf

Fatty Liver Disease : Nash and Related Disorders - part 10 pdf

Ngày tải lên : 10/08/2014, 15:20
... 230 , 230 – 231 future work 238 – 239 histology 235 – 237 adults vs 230 , 235 , 235 , 237 cirrhosis 237 grading/staging 235 imaging 235 pathogenesis 234 – 235 prevalence 231 – 232 obesity correlation 232 treatment ... Gastroenterology 20 03; 125: 1796–807 29 Mofrad P, Contos MJ, Haque M et al Clinical and histologic spectrum of nonalcoholic fatty liver disease asso- 30 31 32 33 34 35 36 37 38 39 40 41 42 43 ciated with ... diabetes 31 weight reduction 196 children (NAFLD/NASH in) 18–19, 27, 229–240 Asians 222 clinical evaluation 234 , 234 clinical presentation 233 – 234 demographics 232 – 233 , 233 differential diagnosis 230 ,...
  • 27
  • 313
  • 0

Xem thêm